Percutaneous coronary intervention (PCI) is associated with a lower risk of a major adverse events, compared with conservative treatment, in patients undergoing transcatheter aortic-valve implantation (TAVI) with coronary artery disease (CAD), reports new 2-year follow-up data from the NOTION-3 study.